9/14 @ 10:45am-12:00pm PT
Thought Leader Series: How are AI and Other Technologies Being Applied to Life Sciences? What is the Impact on Patent Portfolio Building as Life Sciences and High-Tech Converge

We will explore changing business trends, the convergence of life sciences and high-tech, and what it means for patent portfolio strategy.

- What can different industries learn from each other?
- How is life sciences moving increasingly towards high-tech?
- What is the impact on portfolio development and licensing?

Speakers:
- John Byrnes, Associate Technical Director, Artificial Intelligence Center, SRI International
- Maneesh Gupta, IP Counsel, Roche
- Charles Katz, Division IP Counsel, Thermo Fisher Scientific
- Phil McGarrigle, Senior IP Counsel, Jazz Pharmaceuticals
- Michele Simkin, Partner & Chair of IP Group, Foley & Lardner
- Karen Sinclair, Director of IP, Harvard University